Status:
COMPLETED
New Ways to Help Patients Improve Their Diabetes Control
Lead Sponsor:
University of Pennsylvania
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The percent of glycosylated hemoglobin, also known as a hemoglobin A1C value, is the standard way that clinicians assess a patient's diabetes control. Numerous studies have shown that maintaining a he...
Eligibility Criteria
Inclusion
- 1\. Patients over the age of 18 with diabetes mellitus listed as a problem list or in their past medical history on their electronic medical record who have a hemoglobin A1C value greater than 8% within three months of study enrollment.
Exclusion
- Pregnant patients
- Illiterate patients
- Patients with known cognitive deficits affecting ability to participate in study
- Any current participants in another active research study
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT01143870
Start Date
April 1 2010
End Date
July 1 2011
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104